CIK 0001478320 · Large accelerated filer
Adaptive Biotechnologies Corp
Sign in to watch- Ticker
- ADPT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- WA
- Entity type
- operating
- EIN
- 270907024
- Phone
- 206-659-0067
- Business address
- 1165 EASTLAKE AVE E, SEATTLE, WA, 98109
- Former names
- Adaptive TCR Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $32,383,812
- in 18 filings, $13.4M under 10b5-1 plans
Net −$32,383,812. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-25 | GRIFFIN MICHELLE RENEE Director | Option exercise 10b5-1 | +52,084 | $7.80 | $406K | 67,709 |
| 2026-06-25 | GRIFFIN MICHELLE RENEE Director | Sale 10b5-1 | −52,084 | $20.18 | $1.1M | 15,625 |
| 2026-06-25 | GRIFFIN MICHELLE RENEE Director | Option exercise · Stock Option (right to buy) 10b5-1 | −52,084 | 0 | ||
| 2026-06-16 | ROBINS HARLAN S Chief Scientific Officer | Sale 10b5-1 | −6,160 | $18.01 | $111K | 1,405,898 |
| 2026-06-15 | ROBINS HARLAN S Chief Scientific Officer | Sale 10b5-1 | −100,000 | $17.37 | $1.7M | 1,412,058 |
| 2026-06-11 | BOBULSKY SUSAN Chief Commercial Officer, MRD | Sale 10b5-1 | −5,000 | $19.00 | $95K | 411,775 |
| 2026-06-04 | BOBULSKY SUSAN Chief Commercial Officer, MRD | Sale 10b5-1 | −11,000 | $18.00 | $198K | 416,775 |
| 2026-06-04 | LO FRANCIS Chief People Officer | Option exercise 10b5-1 | +5,792 | $12.14 | $70K | 276,946 |
| 2026-06-04 | LO FRANCIS Chief People Officer | Option exercise 10b5-1 | +2,009 | $8.46 | $17K | 278,955 |
| 2026-06-04 | LO FRANCIS Chief People Officer | Option exercise 10b5-1 | +2,344 | $3.99 | $9K | 281,299 |
| 2026-06-04 | LO FRANCIS Chief People Officer | Option exercise 10b5-1 | +9,376 | $8.12 | $76K | 290,675 |
| 2026-06-04 | LO FRANCIS Chief People Officer | Sale 10b5-1 | −39,741 | $17.49 | $695K | 250,934 |
| 2026-06-04 | LO FRANCIS Chief People Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −5,792 | 171,823 | ||
| 2026-06-04 | LO FRANCIS Chief People Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −2,009 | 85,065 | ||
| 2026-06-04 | LO FRANCIS Chief People Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −2,344 | 85,953 | ||
| 2026-06-04 | LO FRANCIS Chief People Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −9,376 | 140,648 | ||
| 2026-05-18 | PISKEL KYLE Chief Financial Officer | Sale | −3,115 | $13.04 | $41K | 256,725 |
| 2026-04-27 | RUBINSTEIN JULIE President and COO | Option exercise 10b5-1 | +14,707 | $8.46 | $124K | 396,839 |
| 2026-04-27 | RUBINSTEIN JULIE President and COO | Sale 10b5-1 | −19,037 | $14.23 | $271K | 377,802 |
| 2026-04-27 | RUBINSTEIN JULIE President and COO | Option exercise · Stock Option (right to buy) 10b5-1 | −14,707 | 45,731 |
Page 11 of 119 · 2,375 trades